The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel
This study is not yet open for participant recruitment.
Verified September 2012 by Meir Medical Center
Sponsor:
Meir Medical Center
Information provided by (Responsible Party):
Arnon Goldberg, Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01686048
First received: September 12, 2012
Last updated: September 14, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Ambrosia is known for its allergenicity in the USA causing hay fever and asthma. Israel has always been considered "clean" of Ambrosia but over the past years growth of Ambrosia plants has been detected in several locations in Israel.
In the proposed study, patients referred for routine allergic evaluation will also be skin tested with Ambrosia allergens, in addition to their regular prick skin tests with all other airborne allergens.
| Condition |
|---|
|
Allergic Rhinitis Asthma Allergic Conjunctivitis Atopic Dermatitis |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
Resource links provided by NLM:
Further study details as provided by Meir Medical Center:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients refered for allergic evaluation
Criteria
Inclusion Criteria:
- Patients with allergic rhinitis, asthma, allergic conjunctivitis or atopic dermatitis who undergo prick skin tests with airborne allergens
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01686048
Contacts
| Contact: Arnon Goldberg, M.D. | 972-9-7472717 | arnong@clalit.org.il |
Locations
| Israel | |
| Arnon Goldberg, M.D., Allergy and Clinical Immunology Unit, Meir Medical Center | Not yet recruiting |
| Kfar-Saba, Israel, 44281 | |
| Contact: Ronit Confino-Cohen, M.D. 972-9-7472811 ronitco@clalit.org.il | |
Sponsors and Collaborators
Meir Medical Center
More Information
No publications provided
| Responsible Party: | Arnon Goldberg, Head, Allergy and Clinical Immunology Unit, Meir Medical Center |
| ClinicalTrials.gov Identifier: | NCT01686048 History of Changes |
| Other Study ID Numbers: | Ambrosia |
| Study First Received: | September 12, 2012 |
| Last Updated: | September 14, 2012 |
| Health Authority: | Israel: Ministry of Health |
Additional relevant MeSH terms:
|
Asthma Conjunctivitis Conjunctivitis, Allergic Dermatitis Dermatitis, Atopic Rhinitis Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases Respiratory Hypersensitivity Hypersensitivity, Immediate |
Hypersensitivity Immune System Diseases Conjunctival Diseases Eye Diseases Skin Diseases Skin Diseases, Genetic Genetic Diseases, Inborn Skin Diseases, Eczematous Nose Diseases Respiratory Tract Infections Otorhinolaryngologic Diseases |
ClinicalTrials.gov processed this record on May 23, 2013